Renal Cancer - Results from #1420

Statin use improves the efficacy of nivolumab in patients with advanced renal cell carcinoma. July 8, 2022

Prognostic value of the ratio of maximum to minimum diameter of primary tumor in metastatic clear cell renal cell carcinoma. July 7, 2022

Comprehensive Evaluation of the m6A Regulator Prognostic Risk Score in the Prediction of Immunotherapy Response in Clear Cell Renal Cell Carcinoma. July 7, 2022

A Decade of Robotic-Assisted Radical Nephrectomy with Inferior Vena Cava Thrombectomy: A Systematic Review and Meta-Analysis of Perioperative Outcomes. July 6, 2022

Advanced nccRCC: what therapeutic options in 2022? July 6, 2022

Diagnostic accuracy of 99mTc-Sestamibi SPECT/CT for characterization of solid renal masses. July 5, 2022

ARL4C Regulates the Progression of Clear Cell Renal Cell Carcinoma by Affecting the Wnt/β-Catenin Signaling Pathway. July 5, 2022

Precision Medicine: An Optimal Approach to Patient Care in Renal Cell Carcinoma. July 4, 2022

The Role of Cytoreductive Nephrectomy and Targeted Therapy on Outcomes of Patients With Metastatic Sarcomatoid Renal Cell Carcinoma: A Population-Based Analysis. July 4, 2022

An oncogenic JMJD6-DGAT1 axis tunes the epigenetic regulation of lipid droplet formation in clear cell renal cell carcinoma. July 1, 2022

A clinical investigation of recurrence and lost follow-up after renal cell carcinoma surgery: a single-center, long-term, large cohort, retrospective study. July 1, 2022

Real World Overall Survival of Patients With Metastatic Renal Cell Carcinoma Treated With Only Available Sunitinib and Pazopanib in First-Line Setting. June 30, 2022

Systemic Immunological Determinants of Oncological Outcomes After Surgery for Localized Renal Cell Carcinoma. June 30, 2022

Therapeutic sequencing in the era of first-line immune checkpoint inhibitor combinations, a novel challenge in patients with metastatic clear-cell renal cell carcinoma. June 29, 2022

A Targetable Myeloid Inflammatory State Governs Disease Recurrence in Clear Cell Renal Cell Carcinoma. June 29, 2022

Unplanned Conversion from Partial to Radical Nephrectomy - An Analysis of Incidence, Etiology, and Risk Factors. June 28, 2022

Impact of dedicated renal enhanced recovery after surgery (RERAS) program on postoperative opioid consumption and evaluation of surgeon-specific compliance to the program. June 28, 2022

Construction and validation of a novel prognostic nomogram for patients with metastatic renal cell carcinoma: a SEER-based study. June 27, 2022

Noncoding-RNA mediated high expression of zinc finger protein 268 suppresses clear cell renal cell carcinoma progression by promoting apoptosis and regulating immune cell infiltration. June 27, 2022

Redo Robotic Partial Nephrectomy for Recurrent Renal Tumors: A Multi-Institutional Analysis. June 24, 2022

Page 72 of 456